title: Functions of peroxisome proliferator-activated receptors (PPAR) in skin homeostasis.
abstract: The peroxisome proliferator-activated receptors (PPAR) are ligand-activated transcription factors that belong to the nuclear hormone receptor family. Three isotypes (PPAR alpha, PPAR beta or delta, and PPAR gamma) with distinct tissue distributions and cellular functions have been found in vertebrates. All three PPAR isotypes are expressed in rodent and human skin. They were initially investigated for a possible function in the establishment of the permeability barrier in skin because of their known function in lipid metabolism in other cell types. In vitro studies using specific PPAR agonists and in vivo gene disruption approaches in mice indeed suggest an important contribution of PPAR alpha in the formation of the epidermal barrier and in sebocyte differentiation. The PPAR gamma isotype plays a role in stimulating sebocyte development and lipogenesis, but does not appear to contribute to epidermal tissue differentiation. The third isotype, PPAR beta, regulates the late stages of sebaceous cell differentiation, and is the most effective isotype in stimulating lipid production in these cells, both in rodents and in humans. In addition, PPAR beta activation has pro-differentiating effects in keratinocytes under normal and inflammatory conditions. Finally, preliminary studies also point to a potential role of PPAR in hair follicle growth and in melanocyte differentiation. By their diverse biological effects on cell proliferation and differentiation in the skin, PPAR agonists or antagonists may offer interesting opportunities for the treatment of various skin disorders characterized by inflammation, cell hyperproliferation, and aberrant differentiation.
authors.affiliation: Center for Integrative Genomics, NCCR Frontiers in Genetics, University of Lausanne, CH-1015 Lausanne, Switzerland.
authors.forename: Nicolas
authors.initials: N
authors.lastname: Di-Poï
authors.forename: Liliane
authors.initials: L
authors.lastname: Michalik
authors.forename: Béatrice
authors.initials: B
authors.lastname: Desvergne
authors.forename: Walter
authors.initials: W
authors.lastname: Wahli
mesh_terms: D000818:Animals; D002454:Cell Differentiation; D049109:Cell Proliferation; D006706:Homeostasis; D006801:Humans; D047492:Peroxisome Proliferator-Activated Receptors / Q000378:metabolism*; D012867:Skin / Q000166:cytology / Q000378:metabolism* / Q000473:pathology; D012871:Skin Diseases / Q000378:metabolism / Q000473:pathology
chemical_list: D047492:Peroxisome Proliferator-Activated Receptors
references.citation: Endocr Rev. 1999 Oct;20(5):649-88
references.pmid: 10529898
references.citation: Development. 2001 Mar;128(5):675-88
references.pmid: 11171393
references.citation: J Cell Biol. 2001 Aug 20;154(4):799-814
references.pmid: 11514592
references.citation: Acta Derm Venereol. 2000 Sep-Oct;80(5):329-34
references.pmid: 11200828
references.citation: J Biol Chem. 2000 Apr 14;275(15):11484-91
references.pmid: 10753967
references.citation: Genes Dev. 2001 Dec 15;15(24):3263-77
references.pmid: 11751632
references.citation: Mol Cell Biol. 1995 Jun;15(6):3012-22
references.pmid: 7539101
references.citation: J Invest Dermatol. 2004 Apr;122(4):971-83
references.pmid: 15102088
references.citation: Mol Cell. 1999 Oct;4(4):611-7
references.pmid: 10549292
references.citation: Mol Cell. 1999 Oct;4(4):585-95
references.pmid: 10549290
references.citation: J Invest Dermatol. 1998 Dec;111(6):1116-21
references.pmid: 9856826
references.citation: J Investig Dermatol Symp Proc. 1998 Aug;3(2):75-9
references.pmid: 9734818
references.citation: J Steroid Biochem Mol Biol. 2003 Jun;85(2-5):257-65
references.pmid: 12943711
references.citation: Curr Opin Lipidol. 2003 Apr;14(2):129-35
references.pmid: 12642780
references.citation: J Invest Dermatol. 2000 Sep;115(3):361-7
references.pmid: 10951269
references.citation: Nature. 2000 May 25;405(6785):421-4
references.pmid: 10839530
references.citation: J Invest Dermatol. 2000 Feb;114(2):349-53
references.pmid: 10651997
references.citation: Prog Lipid Res. 2001 Jul;40(4):269-81
references.pmid: 11412892
references.citation: J Dermatol. 1998 Sep;25(9):587-96
references.pmid: 9798345
references.citation: J Invest Dermatol. 1999 Oct;113(4):523-32
references.pmid: 10504436
references.citation: Mol Genet Metab. 2001 Nov;74(3):362-9
references.pmid: 11708867
references.citation: J Biol Chem. 1995 Oct 13;270(41):23975-83
references.pmid: 7592593
references.citation: Dermatology. 1998;196(1):43-6
references.pmid: 9557223
references.citation: Mol Endocrinol. 1997 Jun;11(6):779-91
references.pmid: 9171241
references.citation: Mol Cell Biol. 2000 Jul;20(14):5119-28
references.pmid: 10866668
references.citation: J Invest Dermatol. 1999 Feb;112(2):226-32
references.pmid: 9989800
references.citation: Int J Dev Biol. 2002 Jan;46(1):105-14
references.pmid: 11902671
references.citation: Mol Cell Endocrinol. 1999 Jan 25;147(1-2):85-92
references.pmid: 10195695
references.citation: J Invest Dermatol. 1998 Apr;110(4):368-75
references.pmid: 9540977
references.citation: J Invest Dermatol. 1998 Sep;111(3):429-33
references.pmid: 9740236
references.citation: J Clin Invest. 1997 Aug 1;100(3):705-12
references.pmid: 9239419
references.citation: Dermatology. 2003;206(3):252-6
references.pmid: 12673084
references.citation: J Invest Dermatol. 2002 Sep;119(3):576-82
references.pmid: 12230498
references.citation: Endocrinology. 1998 Jun;139(6):2748-54
references.pmid: 9607781
references.citation: Br J Dermatol. 2004 Mar;150(3):462-8
references.pmid: 15030328
references.citation: Endocrinology. 1996 Jan;137(1):354-66
references.pmid: 8536636
references.citation: J Invest Dermatol. 2000 Apr;114(4):681-7
references.pmid: 10733673
references.citation: J Invest Dermatol. 2003 Sep;121(3):441-7
references.pmid: 12925198
references.citation: J Invest Dermatol. 2001 May;116(5):702-12
references.pmid: 11348458
references.citation: Arch Dermatol. 2000 May;136(5):609-16
references.pmid: 10815854
references.citation: J Invest Dermatol. 2002 Dec;119(6):1298-303
references.pmid: 12485431
references.citation: J Invest Dermatol. 2000 Sep;115(3):353-60
references.pmid: 10951268
references.citation: Mol Cell. 2002 Oct;10(4):721-33
references.pmid: 12419217
references.citation: J Invest Dermatol. 1999 Nov;113(5):788-95
references.pmid: 10571735
references.citation: J Invest Dermatol. 2003 Nov;121(5):1104-17
references.pmid: 14708613
references.citation: Horm Res. 2003;60(1):1-13
references.pmid: 12792148